A decreased percentage tumour volume of CD4+ T-lymphocytes (P=0.025, Figure 2) and an elevated C-reactive protein (P<0.001, Figure 3) were also associated with poorer cancer-specific survival. This evidence concerns the gene CD4 and cancer.